(Q42202594)

18 October 2017

title

Cardiovascular and renal actions of calcium channel blocker chemical subgroups: a search for renal specificity (English)

1 reference

18 October 2017

Barrett RJ

1

1 reference

18 October 2017

Wright KF

series ordinal

2

1 reference

18 October 2017

Taylor DR

series ordinal

3

1 reference

18 October 2017

Proakis AG

series ordinal

4

1 reference

18 October 2017

publication date

1 June 1988

1 reference

Journal of Pharmacy and Pharmacology

18 October 2017

published in

1 reference

18 October 2017

volume

40

1 reference

18 October 2017

issue

6

1 reference

18 October 2017

page(s)

408-414

1 reference

Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. Functional, morphological, and mitochondrial studies

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB06305.X

The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB06305.X

Reversal of renal cortical actions of angiotensin II by verapamil and manganese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB06305.X

Sites of action of Ca2+ channel inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB06305.X

The influence of diltiazem and nifedipine on renal function in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB06305.X

Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB06305.X

10.1111/J.2042-7158.1988.TB06305.X

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference